血外体会通过V-ATPase亚单元V1G1破坏α-synuclein的微质降解
Yunna Li1,2, Yiming Wang1, Liang Kou1
1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
CNS neuroscience & therapeutics
|May 4, 2024
概括
帕金森病外基因组通过减少V1G1表达来损害 lysosomal 功能,导致α-synuclein 积累. 过度表达V1G1在帕金森病模型中提供神经保护.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 微质细胞是关键的脑细胞,参与神经炎症和α-synuclein (α-syn) 病理学.
- 众所周知,帕金森病外基因组 (PD-exo) 促进微质细胞中的α-syn聚合和炎症.
- 通过PD-exo影响α-syn降解的确切机制尚不清楚.
研究的目的:
- 研究PD外体对微质中α-syn降解的影响机制.
- 确定V1G1在PD外生体诱导的α-syn积累中的作用.
- 在帕金森病小鼠模型中评估V1G1的治疗潜力.
主要方法:
- 从PD患者的血中分离出外体,并注入小鼠大脑.
- 在微质细胞中评估了溶解体功能,包括pH和酶活性.
- 使用分子生物学技术分析了关键蛋白质 (V1G1,LAMP1,α-syn) 的表达水平.
- 使用帕金森病小鼠模型来评估通过V1G1过度表达的神经保护.
主要成果:
- PD外体减少了V1G1的表达,损害了 lysosomal 酸化和功能.
- 这种溶解体功能障碍导致α-syn积累和蛋白质降解受损.
- 在帕金森病的小鼠模型中,V1G1过度表达显示了神经保护作用.
结论:
- 功能障碍的V型ATPase,特别是V1G1,与帕金森病的发病有关.
- 向V1G1可能为帕金森病提供一种新的治疗策略.
- 在MPTP诱导的帕金森病模型中,V1G1过度表达可以保护神经退行.
更多相关视频
06:43A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
12.1K
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
6.9K
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:13The Proteasome
830
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830